Form 4 for MRVI MARAVAI LIFESCIENCES HOLDINGS, INC.
Accepted 2024-11-12 00:00:00 ET · period of report 2024-10-31 · accession 0001823239-24-000117 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-12 | 2024-10-31 | MRVI | Herde Kevin | CFO | A - Grant | $5.70 | +1,906 | 336.6K | +0.6% | +$10.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-10-31 | A | A | 1,906 | $5.70 | 336,600 | D | — | — |